Mutation patterns and evolutionary action score of <scp> <i>TP53</i> </scp> enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer-Reference-Cited by-同舟云学术

Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer

Published:2022-11-28 Issue:6 Volume:12 Page:6649-6658
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Jiang Wensheng¹,Cheng Huanqing²^ORCID,Yu Lili¹,Zhang Jie¹,Wang Yihui¹,Liang Yun¹,Lou Feng²,Wang Huina²^ORCID,Cao Shanbo²

Affiliation:

1. Department of Cardiothoracic Surgery Yantaishan Hospital Yantai China

2. Department of Medicine Acornmed Biotechnology Co., Ltd. Beijing China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5447

Reference33 articles.

1. Cancer statistics, 2022

2. Non-small cell lung cancer: current treatment and future advances

3. Novel therapeutic targets on the horizon for lung cancer

4. New and emerging targeted treatments in advanced non-small-cell lung cancer

5. Lung cancer: current therapies and new targeted treatments

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications;Biomedicines;2024-06-29

2. Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC);Cancers;2024-06-27

3. Genomic features of lung cancer patients in Indonesia’s national cancer center;BMC Pulmonary Medicine;2024-01-20

4. The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?;Lung Cancer;2023-07